Godlike Productions - Reply to Thread

Users Online Now: 2,000 (Who's On?)	Visitors Today: 1,411,135
Pageviews Today: 2,332,312	Threads Today: 879	Posts Today: 15,810
10:28 PM

REPLY TO THREAD

Subject Japanese flu drug appears ‘effective’ in coronavirus treatment in Chinese clinical trials - Early onset only

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message Based on results of clinical trials conducted with affected patients in both Wuhan and Shenzhen by Chinese medical authorities, Japanese-made flu drug favipiravir (also known as Avigan) has been shown to be effective in both reducing the duration of the COVID-19 virus in patients and to have improved the lung conditions of those who received treatment with the drug.

The trials involved 340 patients in total, and since the drug has already been developed and approved for use in treating flu, it has a “high degree of safety,” according to China science and technology ministry official Zhang Xinmin, who spoke to reporters on Wednesday according to The Guardian. The tests showed a reduction in the period during which patients tested positive for the new coronavirus from 11 days down to just four, and showed improvements in the lung condition of around 91 percent of patients treated with favipiravir, compared to just 62 percent for those without among the trial participants.

more:

[link to techcrunch.com (secure)]

Pictures (click to insert)





\| Next Page >>